A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.


Updates from The Motley Fool

Latest updates on Jazz Pharmaceuticals from Fool.com.


Stock Performance

JAZZ vs. S&P 500 | 2 Year Performance
View Interactive JAZZ Charts
Sponsored by

Key Data Points

Primary metrics and data points about Jazz Pharmaceuticals.
Current Price: $123.79
Prev Close: $127.19
Open: $127.01
Bid: $120.45
Ask: $128.79
Day's Range: $122.89 - $127.01
52wk Range: $108.50 - $160.00
Volume: 731,065
Avg Vol 637,135
Market Cap: $7.61B
P/E (ttm): 22.35
EPS (ttm): $5.69
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Jazz Pharmaceuticals.
CAPS Rating 3 out of 5
 
307 Outperform
67 Underperform
CAPS All Stars
 
69 Outperform
16 Underperform

How do you think Jazz Pharmaceuticals will perform against the market?



You pick for Jazz Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Bruce C. Cozadd, CEO

79% Approve

Based on 14 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Jazz Pharmaceuticals.

A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers